000 01425 a2200397 4500
005 20250517231232.0
264 0 _c20190711
008 201907s 0 0 eng d
022 _a1873-5134
024 7 _a10.1016/j.pec.2018.07.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpronk, P E R
245 0 0 _aCurrent decisions on neoadjuvant chemotherapy for early breast cancer: Experts' experiences in the Netherlands.
_h[electronic resource]
260 _bPatient education and counseling
_c12 2018
300 _a2111-2115 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xmethods
650 0 4 _aDecision Making
650 0 4 _aFemale
650 0 4 _aHealth Care Surveys
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
_xmethods
650 0 4 _aNetherlands
650 0 4 _aOncologists
650 0 4 _aTreatment Outcome
700 1 _ade Ligt, K M
700 1 _avan Bommel, A C M
700 1 _aSiesling, S
700 1 _aSmorenburg, C H
700 1 _aVrancken Peeters, M T F D
773 0 _tPatient education and counseling
_gvol. 101
_gno. 12
_gp. 2111-2115
856 4 0 _uhttps://doi.org/10.1016/j.pec.2018.07.012
_zAvailable from publisher's website
999 _c28677402
_d28677402